Lactose (India) Ltd | 144 Cr. | 102 | 247/84.3 | 20.8 | 36.5 | 0.00 % | 18.0 % | 15.5 % | 10.0 |
MPS Pharmaa Ltd | 5.79 Cr. | 3.03 | 4.33/3.03 | | 0.80 | 0.00 % | 9.15 % | 34.9 % | 10.0 |
Gujarat Themis Biosyn Ltd | 2,663 Cr. | 244 | 390/192 | 50.6 | 20.5 | 0.27 % | 45.0 % | 33.8 % | 1.00 |
Gujarat Terce Laboratories Ltd | 46.7 Cr. | 62.9 | 94.9/44.5 | 15.8 | 11.9 | 0.00 % | 9.72 % | 3.44 % | 10.0 |
Gujarat Inject (Kerala) Ltd | 38.1 Cr. | 26.0 | 29.0/8.74 | 38.9 | 6.64 | 0.00 % | 2.65 % | 2.08 % | 10.0 |
Godavari Drugs Ltd | 73.8 Cr. | 98.0 | 155/79.0 | 11.9 | 55.4 | 0.00 % | 14.4 % | 15.5 % | 10.0 |
Glenmark Life Sciences Ltd | 13,316 Cr. | 1,084 | 1,335/666 | 31.4 | 207 | 2.07 % | 28.1 % | 21.1 % | 2.00 |
Gennex Laboratories Ltd | 315 Cr. | 13.8 | 29.0/11.4 | 16.9 | 7.93 | 0.00 % | 14.1 % | 10.2 % | 1.00 |
Ganga Pharmaceuticals Ltd | 4.92 Cr. | 10.2 | 27.1/9.25 | 98.4 | 14.6 | 0.00 % | 3.06 % | 0.80 % | 10.0 |
Fredun Pharmaceuticals Ltd | 331 Cr. | 700 | 1,024/635 | 17.6 | 277 | 0.10 % | 17.1 % | 14.3 % | 10.0 |
Fervent Synergies Ltd | 95.0 Cr. | 21.7 | 32.0/14.6 | | 8.11 | 0.00 % | 34.8 % | 34.9 % | 10.0 |
Fermenta Biotech Ltd | 876 Cr. | 298 | 449/145 | 24.8 | 98.6 | 0.42 % | 3.20 % | 5.59 % | 5.00 |
Fabino Enterprises Ltd | 5.15 Cr. | 24.5 | 37.6/22.8 | 103 | 20.0 | 0.00 % | 1.68 % | 1.21 % | 10.0 |
Evoq Remedies Ltd | 6.50 Cr. | 2.61 | 12.3/2.11 | | 17.2 | 0.00 % | 1.91 % | 1.80 % | 10.0 |
Everest Organics Ltd | 277 Cr. | 285 | 307/112 | | 50.6 | 0.00 % | 6.05 % | 0.30 % | 10.0 |
Entero Healthcare Solutions Ltd | 5,034 Cr. | 1,157 | 1,584/991 | 55.9 | 387 | 0.00 % | 6.71 % | 4.98 % | 10.0 |
Murae Organisor Ltd | 123 Cr. | 1.32 | 2.72/1.03 | 26.0 | 2.85 | 0.00 % | 0.79 % | 0.13 % | 2.00 |
Dipna Pharmachem Ltd | 35.7 Cr. | 14.8 | 16.6/6.40 | 43.0 | 15.8 | 0.00 % | 7.05 % | 3.52 % | 10.0 |
Decipher Labs Ltd | 11.6 Cr. | 11.5 | 24.6/10.1 | 50.5 | 21.3 | 0.00 % | 3.09 % | 6.75 % | 10.0 |
Coral Laboratories Ltd | 258 Cr. | 724 | 999/355 | 9.51 | 570 | 0.28 % | 12.6 % | 9.58 % | 10.0 |
Concord Drugs Ltd | 31.9 Cr. | 31.9 | 45.0/26.1 | | 33.9 | 0.00 % | 4.48 % | 1.28 % | 10.0 |
Colinz Laboratories Ltd | 27.0 Cr. | 59.0 | 88.7/36.0 | 55.1 | 20.5 | 0.00 % | 7.70 % | 5.73 % | 10.0 |
Cian Healthcare Ltd | 8.02 Cr. | 3.21 | 26.5/2.97 | | 15.8 | 0.00 % | 5.22 % | 0.43 % | 10.0 |
Chemo Pharma Laboratories Ltd | 19.8 Cr. | 132 | 154/55.1 | 49.6 | 91.1 | 0.00 % | 13.3 % | 9.67 % | 10.0 |
Checkpoint Trends Ltd | 8.08 Cr. | 14.8 | 19.4/6.08 | | 0.93 | 0.00 % | 3.36 % | 5.77 % | 10.0 |
Chandra Bhagat Pharma Ltd | 45.2 Cr. | 60.0 | 124/50.0 | 28.6 | 39.4 | 0.00 % | 7.95 % | 5.42 % | 10.0 |
Brawn Biotech Ltd | 4.88 Cr. | 16.3 | 27.8/15.5 | | 14.1 | 0.00 % | 25.9 % | 21.8 % | 10.0 |
Blue Jet Healthcare Ltd | 12,795 Cr. | 738 | 969/347 | 54.5 | 53.3 | 0.13 % | 30.0 % | 22.4 % | 2.00 |
Bharat Immunological & Biological Corporation Ltd | 97.2 Cr. | 22.5 | 35.9/19.0 | | 18.2 | 0.00 % | 9.27 % | 17.7 % | 10.0 |
Beryl Drugs Ltd | 11.8 Cr. | 23.2 | 46.0/20.3 | 147 | 18.3 | 0.00 % | 11.6 % | 8.95 % | 10.0 |
BDH Industries Ltd | 160 Cr. | 277 | 418/245 | 16.4 | 110 | 1.62 % | 20.6 % | 16.9 % | 10.0 |
Bacil Pharma Ltd | 27.0 Cr. | 45.9 | 62.6/14.8 | 77.2 | 2.87 | 0.00 % | 13.1 % | 13.8 % | 10.0 |
Aurobindo Pharma Ltd | 62,019 Cr. | 1,058 | 1,593/1,031 | 17.4 | 527 | 0.39 % | 14.1 % | 11.5 % | 1.00 |
Auro Laboratories Ltd | 161 Cr. | 258 | 307/156 | 46.2 | 69.6 | 0.00 % | 20.4 % | 20.5 % | 10.0 |
Anuh Pharma Ltd | 883 Cr. | 176 | 261/148 | 17.6 | 60.5 | 1.41 % | 25.6 % | 19.5 % | 5.00 |
ANG Lifesciences India Ltd | 36.0 Cr. | 27.6 | 63.2/21.0 | | 56.2 | 0.00 % | 1.78 % | 8.72 % | 10.0 |
Ami Organics Ltd | 9,627 Cr. | 2,352 | 2,644/1,008 | 79.1 | 294 | 0.12 % | 16.0 % | 9.37 % | 10.0 |
Amerise Biosciences Ltd | 6.14 Cr. | 0.93 | 1.45/0.55 | | 0.80 | 0.00 % | 2.73 % | 2.75 % | 1.00 |
Ambalal Sarabhai Enterprises Ltd | 299 Cr. | 39.0 | 77.7/34.1 | 21.0 | 18.3 | 0.00 % | 7.08 % | 4.22 % | 10.0 |
Adline Chem Lab Ltd | 6.69 Cr. | 11.4 | 27.3/11.4 | | 2.70 | 0.00 % | % | % | 10.0 |
Achyut Healthcare Ltd | 74.2 Cr. | 3.15 | 6.25/2.82 | 112 | 1.32 | 0.00 % | 3.27 % | 2.52 % | 1.00 |
Abbott India Ltd | 62,441 Cr. | 29,384 | 31,900/25,200 | 46.8 | 1,657 | 1.39 % | 46.0 % | 34.9 % | 10.0 |
Aarti Pharmalabs Ltd | 6,565 Cr. | 724 | 837/430 | 26.4 | 205 | 0.38 % | 16.6 % | 13.1 % | 5.00 |
Aarey Drugs & Pharmaceuticals Ltd | 132 Cr. | 46.4 | 75.8/31.3 | 23.1 | 47.8 | 0.00 % | 6.09 % | 3.74 % | 10.0 |
Zota Health Care Ltd | 2,253 Cr. | 817 | 1,078/440 | | 57.7 | 0.12 % | 7.32 % | 16.8 % | 10.0 |
Wockhardt Ltd | 21,919 Cr. | 1,349 | 1,680/489 | | 209 | 0.00 % | 0.83 % | 12.1 % | 5.00 |
Wanbury Ltd | 806 Cr. | 246 | 325/131 | 43.4 | 11.8 | 0.00 % | 60.6 % | % | 10.0 |
Vivimed Labs Ltd | 41.0 Cr. | 4.95 | / | | 3.12 | 0.00 % | 9.38 % | 233 % | 2.00 |
Venus Remedies Ltd | 417 Cr. | 312 | 428/270 | 15.0 | 370 | 0.00 % | 8.57 % | 5.94 % | 10.0 |
Unichem Laboratories Ltd | 4,654 Cr. | 661 | 950/433 | 55.0 | 341 | 0.00 % | 0.39 % | 1.17 % | 2.00 |
TTK Healthcare Ltd | 1,787 Cr. | 1,265 | 1,923/1,060 | 26.1 | 735 | 0.79 % | 8.67 % | 6.43 % | 10.0 |
Torrent Pharmaceuticals Ltd | 1,09,144 Cr. | 3,225 | 3,591/2,505 | 58.6 | 222 | 0.87 % | 23.2 % | 24.2 % | 5.00 |
Themis Medicare Ltd | 1,330 Cr. | 145 | 317/142 | 28.8 | 44.8 | 0.33 % | 13.5 % | 11.8 % | 1.00 |
Syncom Formulations (India) Ltd | 1,612 Cr. | 17.2 | 27.9/11.0 | 42.3 | 3.32 | 0.00 % | 10.2 % | 8.51 % | 1.00 |
Suven Pharmaceuticals Ltd | 27,908 Cr. | 1,096 | 1,360/597 | 100 | 77.7 | 0.00 % | 18.8 % | 14.1 % | 1.00 |
Suven Life Sciences Ltd | 2,931 Cr. | 134 | 169/83.0 | | 8.84 | 0.00 % | 36.4 % | 36.3 % | 1.00 |
Sun Pharmaceuticals Industries Ltd | 4,07,923 Cr. | 1,700 | 1,960/1,377 | 34.6 | 288 | 0.77 % | 17.3 % | 16.7 % | 1.00 |
Solara Active Pharma Sciences Ltd | 2,190 Cr. | 521 | 886/361 | | 301 | 0.00 % | 8.67 % | 33.5 % | 10.0 |
SMS Pharmaceuticals Ltd | 1,849 Cr. | 218 | 398/175 | 29.0 | 70.6 | 0.18 % | 11.2 % | 9.27 % | 1.00 |
SMS Lifesciences India Ltd | 354 Cr. | 1,170 | 1,750/626 | 16.8 | 621 | 0.12 % | 6.89 % | 3.66 % | 10.0 |
Shilpa Medicare Ltd | 6,253 Cr. | 639 | 960/418 | 73.9 | 238 | 0.00 % | 5.25 % | 1.71 % | 1.00 |
Sequent Scientific Ltd | 3,414 Cr. | 136 | 241/91.8 | 227 | 27.2 | 0.00 % | 0.44 % | 3.09 % | 2.00 |
Sanofi India Ltd | 13,754 Cr. | 5,972 | 7,600/4,146 | 38.0 | 374 | 1.97 % | 49.2 % | 38.6 % | 10.0 |
RPG Life Sciences Ltd | 3,647 Cr. | 2,205 | 2,977/1,381 | 38.2 | 229 | 0.70 % | 34.6 % | 25.5 % | 8.00 |
Procter & Gamble Health Ltd | 8,617 Cr. | 5,191 | 5,850/4,637 | 35.1 | 368 | 1.54 % | 45.0 % | 33.5 % | 10.0 |
Pharmaids Pharmaceuticals Ltd | 242 Cr. | 68.7 | 87.5/31.9 | | 19.0 | 0.00 % | 27.6 % | 16.8 % | 10.0 |
Pfizer Ltd | 18,297 Cr. | 4,000 | 6,453/3,865 | 29.7 | 820 | 0.86 % | 22.0 % | 16.1 % | 10.0 |
Par Drugs & Chemicals Ltd | 119 Cr. | 97.0 | 348/81.0 | 7.73 | 78.6 | 0.00 % | 25.0 % | 18.5 % | 10.0 |
Panacea Biotec Ltd | 2,766 Cr. | 452 | 491/112 | | 136 | 0.00 % | 3.57 % | 3.17 % | 1.00 |
Ortin Laboratories Ltd | 16.4 Cr. | 20.1 | 26.4/16.2 | | 3.47 | 0.00 % | 60.2 % | 118 % | 10.0 |
Orchid Pharma Ltd | 3,880 Cr. | 765 | 1,998/758 | 35.2 | 241 | 0.00 % | 9.37 % | 9.94 % | 10.0 |
Neuland Laboratories Ltd | 14,960 Cr. | 11,660 | 18,100/5,540 | 62.4 | 1,087 | 0.12 % | 33.3 % | 26.4 % | 10.0 |
Nectar Lifescience Ltd | 550 Cr. | 24.5 | 56.5/21.8 | 32.3 | 48.1 | 0.00 % | 5.97 % | 0.46 % | 1.00 |
Natco Pharma Ltd | 14,365 Cr. | 802 | 1,639/757 | 7.71 | 399 | 1.17 % | 30.1 % | 25.9 % | 2.00 |
Morepen Laboratories Ltd | 2,752 Cr. | 50.2 | 101/42.0 | 21.8 | 20.3 | 0.00 % | 16.8 % | 12.0 % | 2.00 |
Marksans Pharma Ltd | 9,800 Cr. | 216 | 359/130 | 26.7 | 50.3 | 0.27 % | 20.6 % | 16.5 % | 1.00 |
Mangalam Drugs and Organics Ltd | 126 Cr. | 79.4 | 145/70.1 | 12.2 | 93.2 | 0.00 % | 1.19 % | 6.12 % | 10.0 |
Lyka Labs Ltd | 373 Cr. | 104 | 177/90.2 | 90.9 | 27.7 | 0.00 % | 3.53 % | 5.07 % | 10.0 |
Lupin Ltd | 89,487 Cr. | 1,960 | 2,403/1,493 | 31.2 | 343 | 0.39 % | 15.7 % | 14.1 % | 2.00 |
Lincoln Pharmaceuticals Ltd | 1,121 Cr. | 560 | 980/498 | 12.5 | 319 | 0.31 % | 22.3 % | 16.8 % | 10.0 |
Laurus Labs Ltd | 31,147 Cr. | 578 | 646/385 | 125 | 79.2 | 0.13 % | 7.50 % | 5.43 % | 2.00 |
Kwality Pharmaceuticals Ltd | 880 Cr. | 848 | 1,070/441 | 24.9 | 234 | 0.00 % | 15.9 % | 13.7 % | 10.0 |
Krebs Biochemicals & Industries Ltd | 154 Cr. | 71.3 | 129/60.3 | | 60.4 | 0.00 % | 19.0 % | % | 10.0 |
Kopran Ltd | 912 Cr. | 189 | 370/156 | 19.2 | 103 | 1.58 % | 13.8 % | 11.0 % | 10.0 |
Kilitch Drugs (India) Ltd | 564 Cr. | 350 | 405/294 | 31.5 | 118 | 0.00 % | 12.6 % | 7.71 % | 10.0 |
Jubilant Pharmova Ltd | 14,895 Cr. | 935 | 1,310/608 | 44.7 | 373 | 0.54 % | 6.74 % | 0.76 % | 1.00 |
J B Chemicals & Pharmaceuticals Ltd | 23,626 Cr. | 1,518 | 2,030/1,434 | 36.9 | 207 | 0.79 % | 24.6 % | 20.0 % | 1.00 |
Jagsonpal Pharmaceuticals Ltd | 1,451 Cr. | 218 | 328/109 | 39.8 | 29.7 | 0.90 % | 17.0 % | 13.0 % | 2.00 |
Ipca Laboratories Ltd | 35,463 Cr. | 1,398 | 1,758/1,052 | 48.3 | 264 | 0.27 % | 12.8 % | 9.35 % | 1.00 |
IOL Chemicals & Pharmaceuticals Ltd | 1,840 Cr. | 62.7 | 108/58.6 | 18.8 | 56.5 | 1.60 % | 12.3 % | 8.68 % | 2.00 |
Ind-Swift Ltd | 75.4 Cr. | 13.9 | 34.7/12.5 | 1.16 | 122 | 0.00 % | 13.4 % | % | 2.00 |
Ind-Swift Laboratories Ltd | 510 Cr. | 86.4 | 186/81.5 | 6.17 | 171 | 0.00 % | 19.6 % | 17.4 % | 10.0 |
Indoco Remedies Ltd | 2,271 Cr. | 246 | 388/190 | | 118 | 0.62 % | 10.4 % | 8.33 % | 2.00 |
Hikal Ltd | 5,100 Cr. | 414 | 465/267 | 68.5 | 97.6 | 0.28 % | 7.79 % | 5.97 % | 2.00 |
Hester Biosciences Ltd | 1,500 Cr. | 1,763 | 3,379/1,243 | 48.5 | 355 | 0.32 % | 9.32 % | 6.60 % | 10.0 |
Gufic BioSciences Ltd | 3,340 Cr. | 333 | 504/278 | 40.7 | 57.3 | 0.03 % | 17.2 % | 20.0 % | 1.00 |
Granules India Ltd | 11,193 Cr. | 462 | 725/382 | 23.4 | 141 | 0.31 % | 15.4 % | 13.4 % | 1.00 |
Glenmark Pharmaceuticals Ltd | 42,242 Cr. | 1,497 | 1,831/985 | | 299 | 0.16 % | 12.3 % | 50.9 % | 1.00 |
Glaxosmithkline Pharmaceuticals Ltd | 46,610 Cr. | 2,751 | 3,088/1,825 | 54.6 | 98.7 | 1.15 % | 51.3 % | 37.3 % | 10.0 |
Gland Pharma Ltd | 24,209 Cr. | 1,469 | 2,221/1,411 | 21.6 | 557 | 1.29 % | 16.7 % | 12.3 % | 1.00 |
FDC Ltd | 6,565 Cr. | 403 | 659/364 | 24.0 | 141 | 1.23 % | 18.4 % | 14.2 % | 1.00 |
ERIS Lifesciences Ltd | 18,355 Cr. | 1,348 | 1,594/816 | 55.8 | 204 | 0.52 % | 11.3 % | 16.3 % | 1.00 |
Dr Reddys Laboratories Ltd | 92,291 Cr. | 1,106 | 1,421/1,077 | 17.2 | 369 | 0.70 % | 26.5 % | 21.4 % | 1.00 |
Dishman Carbogen Amcis Ltd | 3,336 Cr. | 213 | 308/133 | | 366 | 0.00 % | 0.02 % | 2.64 % | 2.00 |
Cipla Ltd | 1,14,056 Cr. | 1,412 | 1,702/1,317 | 22.9 | 351 | 0.88 % | 22.8 % | 16.8 % | 2.00 |
Caplin Point Laboratories Ltd | 14,990 Cr. | 1,972 | 2,641/1,221 | 29.1 | 334 | 0.25 % | 26.5 % | 24.2 % | 2.00 |
Brooks Laboratories Ltd | 314 Cr. | 120 | 203/72.5 | | 22.6 | 0.00 % | 24.7 % | 28.1 % | 10.0 |
Bliss GVS Pharma Ltd | 1,290 Cr. | 122 | 186/92.2 | 15.2 | 95.8 | 0.40 % | 14.4 % | 10.2 % | 1.00 |
Biofil Chemicals & Pharmaceuticals Ltd | 75.7 Cr. | 46.5 | 92.0/40.4 | 126 | 11.3 | 0.00 % | 4.94 % | 4.00 % | 10.0 |
Biocon Ltd | 39,554 Cr. | 329 | 405/260 | 48.1 | 175 | 0.14 % | 5.96 % | 5.25 % | 5.00 |
Beta Drugs Ltd | 1,898 Cr. | 1,880 | 2,215/1,048 | 46.3 | 179 | 0.00 % | 32.8 % | 26.0 % | 10.0 |
Bal Pharma Ltd | 187 Cr. | 118 | 158/76.3 | 25.8 | 43.2 | 1.05 % | 12.1 % | 11.0 % | 10.0 |
Bafna Pharmaceuticals Ltd | 175 Cr. | 74.0 | 113/67.8 | 37.5 | 35.0 | 0.00 % | 9.48 % | 9.44 % | 10.0 |
Astrazeneca Pharma India Ltd | 19,740 Cr. | 7,896 | 9,059/4,800 | 118 | 272 | 0.30 % | 31.1 % | 22.9 % | 2.00 |
Amrutanjan Health Care Ltd | 1,908 Cr. | 660 | 863/548 | 38.7 | 103 | 0.70 % | 21.3 % | 15.5 % | 1.00 |
Alpa Laboratories Ltd | 236 Cr. | 112 | 145/69.9 | 9.39 | 83.0 | 0.00 % | 13.7 % | 11.2 % | 10.0 |
Alkem Laboratories Ltd | 57,438 Cr. | 4,804 | 6,440/4,407 | 26.6 | 961 | 0.81 % | 19.7 % | 19.6 % | 2.00 |
Alembic Pharmaceuticals Ltd | 17,330 Cr. | 882 | 1,304/725 | 29.2 | 249 | 1.26 % | 13.1 % | 13.3 % | 2.00 |
Albert David Ltd | 479 Cr. | 839 | 1,754/795 | 11.9 | 724 | 1.36 % | 27.8 % | 21.7 % | 10.0 |
Ajanta Pharma Ltd | 31,041 Cr. | 2,485 | 3,486/2,050 | 34.6 | 294 | 1.39 % | 31.6 % | 23.2 % | 2.00 |
Advanced Enzyme Technologies Ltd | 3,149 Cr. | 282 | 571/258 | 22.1 | 120 | 1.84 % | 15.2 % | 11.2 % | 2.00 |
Aarti Drugs Limited | 3,064 Cr. | 333 | 635/330 | 23.2 | 126 | 0.29 % | 13.7 % | 12.4 % | 10.0 |
Industry Average | 17,397.04 Cr | 1,073.05 | | 42.07 | 182.59 | 0.35% | 16.01% | 16.31% | 6.24 |